primary aldosteronism

26
Primary Aldosteronism Paul S. Kellerman, M.D., FACP Associate Professor Division of Nephrology

Upload: lidia

Post on 30-Jan-2016

101 views

Category:

Documents


1 download

DESCRIPTION

Primary Aldosteronism. Paul S. Kellerman, M.D., FACP Associate Professor Division of Nephrology. 65,000,000, 31% of adults (1999-2000) (Fields et al, Hypertension, October 2004). EPIDEMIOLOGY OF HYPERTENSION. U.S. PREVALENCE 50,000,000, 27% of adults (1988-94) - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Primary Aldosteronism

Primary Aldosteronism

Paul S. Kellerman, M.D., FACPAssociate Professor

Division of Nephrology

Page 2: Primary Aldosteronism

EPIDEMIOLOGY OF HYPERTENSION

U.S. PREVALENCE

50,000,000, 27% of adults (1988-94)

WORLDWIDE PREVALENCE 1,000,000,000

65,000,000, 31% of adults (1999-2000) (Fields et al, Hypertension, October 2004)

Page 3: Primary Aldosteronism

FREQUENCY OF VARIOUS DIAGNOSES IN HYPERTENSIVE PATIENTS – 1980s

PRIMARY CARE REFERRAL

Essential 92-95% 89%

Chronic kidney dis 3-6% 5%

Renovascular dis 0.2-1.0% 4%

Pheochromocytoma 0.1-0.2% 0.2%

Aldosteronism 0.1-0.3% 0.5%

Cushing’s syndrome 0.1-0.2% 0.2%

Coarctation 0.1-0.2% 1%

Oral contraceptives 0.2-1.0%

Page 4: Primary Aldosteronism

DIFFERENTIATION OF SECONDARY FROM ESSENTIAL HYPERTENSION

• Know presentation and course of essential hypertension

• Know signs and symptoms of secondary etiologies

Page 5: Primary Aldosteronism

Essential Hypertension• Onset in 30s and 40s• Gradual onset• Gradual progression of HTN/slow addition of

medications• Lack of severe end-organ damage• Family history• Often associated with obesity• Lack of signs and symptoms of secondary

causes• Lack of laboratory evidence of secondary causes

Page 6: Primary Aldosteronism

Secondary Hypertension• Hypertension onset at age extremes <30 >50• Rapid onset of severe hypertension• More severe chronic end-organ damage

– Grade III/IV retinopathy, LVH/CHF, CKD

• Lack of family history• Sign and symptoms of secondary etiologies• Laboratory evidence of secondary etiologies• Emergent hypertension• Resistant hypertension

Page 7: Primary Aldosteronism

Primary AldosteronismSecondary cause of hypertension due to excessive secretion of aldosterone from the adrenal gland, due either to tumor or hyperplasia.

Page 8: Primary Aldosteronism
Page 9: Primary Aldosteronism
Page 10: Primary Aldosteronism

FREQUENCY OF VARIOUS DIAGNOSES IN HYPERTENSIVE PATIENTS - 2007

PRIMARY CARE REFERRAL

Essential 92-95% 89%

Chronic kidney dis 3-6% 5%

Renovascular dis 0.2-1.0% 4%

Pheochromocytoma 0.1-0.2% 0.2%

Aldosteronism 5-13%

Cushing’s syndrome 0.1-0.2% 0.2%

Coarctation 0.1-0.2% 1%

Oral contraceptives 0.2-1.0%

Page 11: Primary Aldosteronism

DDx of Aldosteronism from Essential Hypertension

Aldo-Producing

Adenoma

Adrenal Hyperplasia

Low-renin essential HTN

Age Middle-aged Older Older

Hypokalemia Frequent Less common Uncommon

Plasma renin levels

Very low Low Low

Plasma aldo levels

Very high High-normal Normal

Plasma aldo suppressibility to volume

Minimal Partial Complete

Page 12: Primary Aldosteronism

Young WF, Endocrinology 144:2208-13, 2003.

Page 13: Primary Aldosteronism

When to Screen for Aldosteronism

• Hypertension and Spontaneous Hypokalemia

• Hypertension and Adrenal Tumor

• Resistant Hypertension (20% incidence)

Page 14: Primary Aldosteronism

Incidence of Aldosteronism Increases with Hypertension

Severity

Mosso L et al. Hypertension 42:161, 2003

Page 15: Primary Aldosteronism

Laboratory Screening

• Plasma aldosterone concentration (PAC) and plasma renin activity (PRA)

• Drawn from ambulant seated patient

• Morning blood draw

• Potassium must be normalized (not hypokalemic) to avoid false suppression of aldosterone

Page 16: Primary Aldosteronism

Positive Screening Meriting Further Investigation for PA

Aldosterone-Renin Ratio (ARR)>30 (20-60?) – PRA is normalized to 0.5 if <0.5

AND

Aldosterone level>15 ng/dL

Page 17: Primary Aldosteronism

Potential Alterations in ARR with Medications

• Beta-blockers– False +ARR (lower renin, but also therefore lower aldosterone)

• Angiotensin receptor blockers (>ACE Inh)– False –ARR (lower aldosterone, raises renin)

• Diuretics– With thiazides and loop diuretics, may not be much effect,

since raise both aldo and renin, so ratio doesn’t change much– Spironolactone should be stopped (increased aldosterone)

• Calcium channel blockers– Minimal effects

May not matter for ARR (Gallay BJ, et al. Am J Kidney Dis 37:699-705, 2001)

Do we need to stop medications for ARR?

Page 18: Primary Aldosteronism

Aldosterone Suppression Tests

• IV Saline suppression – 500 mL 0.9% NaCl/hr for four hours OR 500 mL 0.9% NaCl over 30

minutes, then 500 mL/hr for 2 hours (1.5 liters over 2.5 hours)• Draw PAC at time 0, 120, 150 minutes for short test

– Suppression if PAC <8.5 ng/dL (<6 normal >10 PA)

• Oral sodium chloride suppression test– 10 gms NaCl daily for 4 days– On day 4, collect 24 hour urine aldosterone, sodium

– Suppression if aldosterone<14 mcg and sodium > 200 mEq/24 hours

• Fludrocortisone suppression test – high salt diet and large doses of Florinef over a 4 day hospitalization

%ARR with lack of suppression – mean 60% , range 26-95% (Kaplan NM, J Hypertension 22:863-69, 2004)

Page 19: Primary Aldosteronism

Imaging for Aldosteronism• CT – thin cuts of adrenal glands• MRI• 131-I-iodocholesterol

Page 20: Primary Aldosteronism

Imaging for Aldosteronism

• Problems with CT/MRI– Lots of False Positives

• Only can image adenoma if > 1cm• Of these, 1/3 are incidentaloma (no

lateralization on adrenal vein sampling)

– Lots of False Negatives• Up to 1/3 of adenomas are missed

because of small size (lateralize on adrenal vein sampling)

Page 21: Primary Aldosteronism

Role for Adrenal Vein Sampling

When to use:

Unilateral adenoma > 40 years old

“High risk APA” with normal adrenals on CT scan or mild asymmetry

Page 22: Primary Aldosteronism

Role for Adrenal Vein Sampling

“High Probability” APA

Severe HTN

Hypokalemia (<3)

Higher Aldo levels

plasma >25 ng/dL

urine > 30 mcg/24 hrs

Age < 50

BUT: AVS is only good in very experienced hands – technically very difficult

Page 23: Primary Aldosteronism

Therapy

• If tumor with lateralization, laparascopic adrenalectomy

• If tumor without lateralization (incidentaloma), or hyperplasia, then aldosterone blockade– Spironolactone– Eplerinone

Page 24: Primary Aldosteronism

Primary Aldosteronism in 2007• The incidence of primary aldosteronism due to adrenal

hyperplasia as defined by saline suppression is much higher than previously thought.

• Hypokalemia is often not present with hyperplasia and is not a sine qua non for diagnosis.

• Resistant hypertensives have a high incidence of primary aldosteronism.

• Controversy exists as to definitive ARR thresholds, medication use during suppression testing, and adrenal imaging.

• AVS is the “gold standard” but not often available due to technical limitations

Page 25: Primary Aldosteronism

Case

• Does she have hyperaldosteronism?– Likely, but not confirmed

• If so, is this hyperplasia or adenomatous (did the CT miss it)?– Unlikely adenoma, given age, very

mild hypokalemia (almost normokalemia), HTN severity

• Is the treatment appropriate?

Page 26: Primary Aldosteronism

UW HYPERTENSION CLINIC

• Multidisciplinary HTN clinic– Nephrology (Kellerman)– Cardiology (Moncher)– Endocrinology (Shenker)

• At the UW Kidney Clinic on Fish Hatchery Road

• 270-5656